Comparison

Anti-Acetyl Lysine Mouse Monoclonal Antibody

Item no. AAC02
Manufacturer Cytoskeleton
Amount 2 x 100 ul
Quantity options 2 x 100 ul 1 x 25 ul 4 x 500 ul
Category
Type Antibody Monoclonal
Clone 7B5A1
Specific against other
Citations 1 Bogdan P. and Sherman F. 2002. The diversity of acetylated proteins. Genome Biol. 3 (5): reviews 0006.
2 Lundby A. et al. 2012. Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and cellular patterns. Cell Reports 2:419-431.
3 Sadoul K. et al. 2010. The tale of protein lysine acetylation in the cytoplasm. J. Biomed. Biotech. 2011:1-15.
>4 Golemis EA et. Al, Protein-Protein Interactions, CSHLP, 2005, p67
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping condition Room temperature
Available
Specificity All species
Manufacturer - Isotype
Mouse / IgG2b
Shipping Temperature
AT
Storage Conditions
On Arrival: 4°C
Description
AAC02, Anti-acetyl lysine antibody is a pan-acetyl lysine mouse monoclonal antibody that is part of the Signal-Seeker product line.The Anti-acetyl-lysine antibody recognizes proteins post-translationally modified by acetylation on the epsilon amine groups of lysine residues that occur on 30-50% of all proteins and in particular histones, p53, tubulin and myosin. A proprietary mixture of acetylated proteins was used to produce a highly robust antibody that has been shown to recognize a wide range of acetylated proteins in IP, WB, ChIP and IF applications. This Anti-acetyl-lysine antibody has many advantages when compared to other commercially available antibodies; in particular, it can be used to visualize acetylated mitochondrial proteins by IF.
Weight (grams)
20
RRID 
AB_2884029
Validation Data
Ac-K Antibody White Paper
IF: Ac-K Mitochondria
AAC02, Anti-acetyl lysine antibody is a pan-acetyl lysine mouse monoclonal antibody that is part of the Signal-Seeker product line.The Anti-acetyl-lysine antibody recognizes proteins post-translationally modified by acetylation on the epsilon amine groups of lysine residues that occur on 30-50% of all proteins and in particular histones, p53, tubulin and myosin. A proprietary mixture of acetylated proteins was used to produce a highly robust antibody that has been shown to recognize a wide range of acetylated proteins in IP, WB, ChIP and IF applications. This Anti-acetyl-lysine antibody has many advantages when compared to other commercially available antibodies; in particular, it can be used to visualize acetylated mitochondrial proteins by IF.
Western Blot using Acetyl-Lysine Antibody (AAC02)
Figure 1 Legend
Fig 1: A: Murine tissue extract, 30 ?g brain extract. B: 30 ?g of Cos-7 cell lysate treated with TSA and nicotinamide (+) or untreated (-). Strongly enhanced bands at 55 and 14-16 kDa in TSA-treated lysate correspond to acetylated tubulin and histone proteins, respectively. C: Titration of acetylated BSA. Lanes 1-5 contain 0.5, 0.1, 0.05, 0.01, and 0.005 ng Ac-BSA, lanes 6-7 contain 500 and 1000 ng non-acetylated BSA, respectively. AAC02 was used at a 1:500 dilution following the recommended western blot protocol. To see the full Western blot comparison, see the Optimized Protocols or the product datasheet. Immunoprecipitation using Acetyl-Lysine Antibody
Figure 2 Legend
Fig 2: Cos-7 cells were either treated (+) or untreated (-) with TSA (1 ?M) and nicotinamide (1 mM) for 6 hours. Cell lysates were prepared in BlastR buffer and filter system and 1 mg of lysate per reaction was used for IP of acetylated proteins. 20 ?l of AAC02 was used per IP reaction. Western blots of immunoprecipitated proteins were developed using AAC03-HRP at 1:3000 dilution. To see the full Immunoprecipitation comparison, see the Optimized Protocols or the product datasheet. To see the full Immunofluorescence protocol, see the Optimized Protocols or the product datasheet. To see the full Immunofluorescence protocol, see the Optimized Protocols or the product datasheet. To see the recommended ChIP protocol, see the Optimized Protocols or the product datasheet Acetylation of proteins can occur as a co-translational or post-translational modification (PTM) (1). Co-translational acetylation occurs at the N-terminal of approximately 85% of mammalian proteins, it is irreversible and is thought to be important in protein stability, localization and synthesis (1). Post-translational acetylation occurs on the epsilon amino group of lysine residues as a reversible and highly dynamic PTM that is known to be a key regulator in multiple cellular events, including chromatin structure, transcription, metabolism, signal transduction and cytoskeletal regulation (2-3). To date over 4, 000 proteins have been identified as targets for PTM acetylation which is comparable to phosphorylation in cellular prevelance (3). Antibody AAC01 detects acetyl lysine PTMs.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 x 100 ul
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?